Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial

BACKGROUND: Patients with the metabolic syndrome are more likely to develop type 2 diabetes and may have an increased risk of cardiovascular disease (CVD) events.We aimed to establish whether CVD event rates were influenced by the metabolic syndrome as defined by the World Health Organisation (WHO),...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Scott, Russell, Donoghoe, Mark, Watts, Gerald F, O'Brien, Richard, Pardy, Christopher, Taskinen, Marja-Riitta, Davis, Timothy ME, Colman, Peter G, Manning, Patrick, Fulcher, Gregory, Keech, Anthony C
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2011
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286386/
https://ncbi.nlm.nih.gov/pubmed/22104275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-10-102
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items